Anthrax Vaccine–Induced Antibodies Provide Cross-Species Prediction of Survival to Aerosol Challenge
- 12 September 2012
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 4 (151), 151ra126
- https://doi.org/10.1126/scitranslmed.3004073
Abstract
Lethal toxin–neutralizing activity in serum after vaccination can provide cross-species predictions of survival against inhalation anthrax.Keywords
This publication has 50 references indexed in Scilit:
- A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trialsBiologicals, 2010
- Evaluating a surrogate endpoint at three levels, with application to vaccine developmentStatistics in Medicine, 2008
- Vaccines: Correlates of Vaccine‐Induced ImmunityClinical Infectious Diseases, 2008
- Interlaboratory Comparison of Results of an Anthrax Lethal Toxin Neutralization Assay for Assessment of Functional Antibodies in Multiple SpeciesClinical and Vaccine Immunology, 2008
- Inhalation Anthrax: Dose Response and Risk AnalysisBiosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 2008
- Mass Value Assignment of Total and Subclass Immunoglobulin G in a Human Standard Anthrax Reference SerumClinical and Vaccine Immunology, 2004
- Validation of the anthrax lethal toxin neutralization assayBiologicals, 2004
- In vitro correlate of immunity in an animal model of inhalational anthraxJournal of Applied Microbiology, 1999
- Statistical validation of intermediate endpoints for chronic diseasesStatistics in Medicine, 1992
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960